Results of a Danish nationwide study confirm that antipsychotic treatment strongly increases risk of mortality in patients with dementia . Adjusted risk of death was increased by about one third. The mortality risk was not influenced by diabetes, cardiovascular, and cerebrovascular comorbidity.
Dr Ane Nørgaard (Rigshospitalet, Denmark) said that there is limited evidence for an effect of antipsychotic treatment on behavioural symptoms and psychosis in dementia. Numbers needed to harm (death of a patient) after 12 weeks of treatment is 100. A matched cohort study was conducted, including all Danish residents aged 65-95 years diagnosed with dementia between 2009 and 2014. Every patient exposed to antipsychotics (n=8,244) was matched with up to three unexposed patients (n=24,730). Total mortality was 5,938 after 180 days of follow-up (3,945 in the unexposed group vs 1,993 in the exposed group). The crude mortality rate per 100 person-years was 36.3 and 58....
please login to read the entire article:
You need to register to read the entire article, please do so now.
« Novel solution of levodopa/carbidopa prodrugs via CSCI Next Article
Panel of inflammation-associated microRNAs as epilepsy biomarker »
Table of Contents: EAN 2019
Alzheimer’s Disease and other Dementias
Parkinson's Disease and other Movement Disorders
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.